Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ; UK Primary Sjögren’s Syndrome Registry. Oni C, et al. Rheumatology (Oxford). 2016 Mar;55(3):544-52. doi: 10.1093/rheumatology/kev373. Epub 2015 Oct 27. Rheumatology (Oxford). 2016. PMID: 26510429 Free PMC article.
The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome.
Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng WF, Fisher BA, Bombardieri M, Astorri E, Empson B, Larkin G, Crampton B, Bowman SJ; British Society for Rheumatology Standards, Guideline and Audit Working Group. Price EJ, et al. Among authors: fisher ba. Rheumatology (Oxford). 2017 Oct 1;56(10):1643-1647. doi: 10.1093/rheumatology/kex163. Rheumatology (Oxford). 2017. PMID: 28957549 No abstract available.
The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome.
Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng WF, Fisher BA, Bombardieri M, Astorri E, Empson B, Larkin G, Crampton B, Bowman SJ; British Society for Rheumatology Standards, Guideline and Audit Working Group. Price EJ, et al. Among authors: fisher ba. Rheumatology (Oxford). 2017 Oct 1;56(10):e24-e48. doi: 10.1093/rheumatology/kex166. Rheumatology (Oxford). 2017. PMID: 28957550 No abstract available.
The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome.
Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng WF, Fisher BA, Bombardieri M, Astorri E, Empson B, Larkin G, Crampton B, Bowman SJ; British Society for Rheumatology Standards, Guideline and Audit Working Group. Price EJ, et al. Among authors: fisher ba. Rheumatology (Oxford). 2017 Oct 1;56(10):1828. doi: 10.1093/rheumatology/kex375. Rheumatology (Oxford). 2017. PMID: 28957572 No abstract available.
B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.
James K, Chipeta C, Parker A, Harding S, Cockell SJ, Gillespie CS, Hallinan J, Barone F, Bowman SJ, Ng WF, Fisher BA; UK Primary Sjögren’s Syndrome Registry. James K, et al. Among authors: fisher ba. Rheumatology (Oxford). 2018 Jul 1;57(7):1222-1227. doi: 10.1093/rheumatology/key063. Rheumatology (Oxford). 2018. PMID: 29608774 Free PMC article.
CXCL13 as biomarker for histological involvement in Sjögren's syndrome.
Colafrancesco S, Priori R, Smith CG, Minniti A, Iannizzotto V, Pipi E, Lucchesi D, Pontarini E, Nayar S, Campos J, Arienzo F, Fusconi M, Cerbelli B, Giordano C, Valesini G, Bombardieri M, Fisher BA, Barone F. Colafrancesco S, et al. Among authors: fisher ba. Rheumatology (Oxford). 2020 Jan 1;59(1):165-170. doi: 10.1093/rheumatology/kez255. Rheumatology (Oxford). 2020. PMID: 31274159
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Ramos-Casals M, Maria A, Suárez-Almazor ME, Lambotte O, Fisher BA, Hernández-Molina G, Guilpain P, Pundole X, Flores-Chávez A, Baldini C, Bingham Iii CO, Brito-Zerón P, Gottenberg JE, Kostine M, Radstake TRD, Schaeverbeke T, Schulze-Koops H, Calabrese L, Khamashta MA, Mariette X; ICIR. Ramos-Casals M, et al. Among authors: fisher ba. Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):114-122. Epub 2019 Aug 28. Clin Exp Rheumatol. 2019. PMID: 31464670 Free article.
127 results